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Abstract Background Microbial infections induce ileal
pancreatitis-associated protein/regenerating gene III (PAP/
RegIII) mRNA expression. Despite increasing interest,
little is known about the PAP/RegIII protein. Therefore,
ileal mucosal PAP/RegIII protein expression, localization,
and fecal excretion were studied in rats upon Salmonella
infection. Results Salmonella infection increased ileal
mucosal PAP/RegIII protein levels in enterocytes located
at the crypt-villus junction. Increased colonization and
translocation of Salmonella was associated with higher
ileal mucosal PAP/RegIII levels and secretion of this pro-
tein in feces. Conclusions PAP/RegIII protein is increased
in enterocytes of the ileal mucosa during Salmonella
infection and is associated with infection severity. PAP/
RegIII is excreted in feces and might be used as a new and
non-invasive infection marker.
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Introduction
Pancreatitis associated protein (PAP) is a type III member
of the regenerating (Reg) gene family and was originally
identified as a lectin-related secretory protein present in rat
pancreatic juice during experimental pancreatitis [21].
Since then, considerable attention has been given to the
Reg family and its structurally related molecules. Recently,
the complex terminology of the Reg family and its iso-
forms was elegantly reviewed [16], and a combined term of
PAP/RegIII was coined to foster a concerted effort in the
investigation of PAP and the isoforms. In this study we
focused on ileal PAP/RegIII in rats, represented by the
genes PAP1 and PAP3. Both genes encode for a protein of
similar size, and these genes are paralogues, which means
that they derive from the same ancestral gene. The rat
PAP3 (alias RegIIIc) and mouse RegIIIc are orthologues,
which means that they are on the amino acid level the most
identical genes between two species (bidirectional best hit).
The other isoform, the rat PAP1 (alias PAP), is the
orthologue of the mouse PAP1 (alias RegIIIb).
Expression of PAP/RegIII mRNA has been shown in the
pancreas of human [40], mouse [39], and rat [19]. More-
over, PAP/RegIII was described as constitutively expressed
in the rat [20] and human [9] small intestine. Intestinal
expression was not altered during acute pancreatitis [20],
indicating that intestinal and pancreatic expressions are
differentially regulated. Interestingly, increased levels of
intestinal PAP/RegIII mRNA have been detected during
active inflammatory bowel disease (IBD), Crohn’s disease,
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and ulcerative colitis in humans [11, 25], and in animal
models of IBD [13, 25, 36]. We recently reported a time-
dependent increase in intestinal PAP/RegIII mRNA, rep-
resented by the genes PAP1 and PAP3, in Salmonella-
infected rats [30, 31]. These results are in line with studies
showing increased PAP/RegIII mRNA upon bacterial col-
onization of the porcine small intestine with Salmonella
[24] and enterotoxigenic Escherichia coli (ETEC) [23].
Hence, it is suggested that PAP/RegIII expression is trig-
gered by increased microbial-epithelial contact and reflects
a state of enhanced host defense [8]. Hitherto, few studies
focused on PAP/RegIII protein levels, and it was not
investigated whether PAP/RegIII expression actually
reflects infection severity or an improved host defense
status.
Furthermore, data on localization of ileal PAP/RegIII
are controversial. PAP/RegIII mRNA is reported to be
present in epithelial cells of the lower villus part [20],
whereas other studies limit expression to Paneth cells in the
ileal crypt bottoms [8].
To investigate intestinal localization and protein levels
of PAP/RegIII, we studied PAP/RegIII expression in the rat
small intestine upon infection with Salmonella enteritidis,
which is a common foodborne pathogen. Our study focused
on the distal ileum, since this area is important in Salmo-
nella infection pathology and sensitive for infection-
induced up-regulation of PAP/RegIII genes [30]. In addi-
tion, we determined whether ileal PAP/RegIII expression
relates to infection severity. Modulation of this infection
severity can be achieved by inoculating animals with dif-
ferent doses of the pathogen, but it has been shown that
Salmonella translocation to organs [17] and the magnitude
of immune response can be irrespective of the inoculated
dose [35]. On the other hand, we have shown in previous
studies that dietary calcium has profound resistance-
enhancing effects and protects against Salmonella and
ETEC infection in rats [2–5] and humans [5]. Therefore,
we performed a dietary calcium intervention in rats to
modulate Salmonella infection severity and to relate well-
established infection markers with intestinal PAP/RegIII
protein expression. More importantly, we determined the
presence of PAP/RegIII in feces and studied the proposed
antimicrobial activity of PAP/RegIII in vitro using fecal
water incubates.
Methods
Diets, Infection, and Dissection of the Rats
The experimental protocol was approved by the animal
welfare committee of Wageningen University (Wagenin-
gen, The Netherlands). Specific pathogen-free male
outbred Wistar rats (WU, Harlan, Horst, The Netherlands),
8 weeks old and with a mean body weight of 245 g, were
housed individually in metabolic cages as described [6].
Rats were fed purified diets containing per kg: 200 g acid
casein, 326 g cornstarch, 174 g glucose, 160 g palm oil,
40 g corn oil, 50 g cellulose, and vitamin and mineral mix
(without calcium) according to AIN-93 [29]. To mimic the
composition of a Western human diet, the prepared diets
were relatively low in calcium and high in fat compared to
standard rodent diets [29]. Diets were supplemented with
CaHPO4  2H2O (Merck, Darmstadt, Germany), at the
expense of glucose, to a final concentration of 30 mmol/kg
(control diet) or 120 mmol/kg (calcium diet). Food intake
was recorded daily, and demineralized drinking water was
supplied ad libitum. Body weight was measured every 2
days before infection and daily after infection. Two groups
were fed the control diet, and another two groups were fed
the calcium-supplemented diet (n = 9 per group). In
addition, five rats were fed the control (n = 3) or calcium
(n = 2) diet, and served as non-infected controls.
Animals were acclimatized to housing and dietary
conditions for 14 days, after which they were orally
infected with 0.5 ml of saline containing 3.109 colony-
forming units of Salmonella enteritidis (clinical isolate,
phage type 4; strain NIZO1241, NIZO food research, Ede,
The Netherlands) as described elsewhere [6]. Animals in
the non-infected group orally received 0.5 ml saline only.
On day 3 or 4 after oral infection, rats from one control
and one calcium-supplemented group were randomly
selected and killed by carbon dioxide inhalation. The non-
infected control rats were also killed by this procedure.
During the dissection, the distal 12 cm of the ileum was
excised. A 2-cm piece from an identical location in each
sample was cut out and preserved in 10% formalin (Sigma–
Aldrich, St Louis, MO) and embedded in paraffin for his-
tological analysis. The remaining parts were cut open
longitudinally and, after flushing with saline, the mucosa
was scraped off and immediately frozen in liquid nitrogen
for RNA isolation and protein analyses, as described
below.
The other infected control and calcium groups were
followed until day 7 after infection to collect fresh fecal
samples with time for Salmonella quantification, as
described elsewhere [4]. In addition, 24-h feces (pooled per
animal per 2 days) and urines were collected before
infection and 7 consecutive days after oral infection. All
24 h feces and urine samples were stored at -20C until
further analysis. Oxytetracycline (Sigma-Aldrich) was
added to the urine collection vessels of the metabolic cages
to prevent bacterial deterioration. Bacterial translocation
was quantified by measuring urinary NOx (sum of nitrate
and nitrite) excretion by using a colorimetric enzymatic kit
(Roche Diagnostics, Basel, Switzerland), as described [38].
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Urinary NOx is a more sensitive and quantitative marker of
intestinal bacterial translocation than culturing of extra-
intestinal organs [12, 26].
Myeloperoxidase Analysis in Ileal Mucosa
Frozen mucosal scrapings of the ileum were pulverized
under liquid nitrogen. Approximately half of the pulverized
tissue was suspended in a 0.2-M sucrose buffer of pH 7.4
containing 20 mM trishydroxymethylaminomethane (Tris),
1 mM dithiothreitol (DTT), and a protease inhibitor
cocktail (Complete, Roche Diagnostics). After mixing and
centrifugation at 14,000g for 20 min, the pellet was
resuspended in acetate-HETAB buffer [0.5% hexadecyl-
trimethylammonium bromide (HETAB) at pH 6.0, 50 mM
sodium acetate, 10 mM ethylenediaminetetraacetic acid
(EDTA), and 0.25 M sucrose] and sonicated on ice for 30 s
at level 2–3 (Sonicator XL2020, Heat Systems, Farming-
dale, NY). The protein concentration of the samples was
determined using BC Assay (Omnilabo, Breda, The
Netherlands) according to the manufacturer’s protocol. A
mouse myeloperoxidase (MPO) ELISA test kit (Hycult
Biotechnology, Uden, The Netherlands), which is cross-
reactive with rat MPO, was used according to the manu-
facturer’s guidelines to determine the concentration of
MPO in mucosal scrapings.
Quantitative Real-Time PCR Analysis of PAP/RegIII,
Represented by PAP1 and PAP3 mRNA, in Ileal
Mucosa
The other half of the pulverized ileal mucosal scrapings
was dissolved in TRIzol reagent (Invitrogen, Carlsbad, CA)
to isolate and purify total RNA as described before [30]. By
using TaqMan Reverse Transcription reagents (Applied
Biosystems Inc., Foster City, CA), copy DNA was created
from 1 lg of RNA on a Perkin Elmer DNA Thermal
Cycler 480, followed by SYBR green-based real-time PCR
on a 7500 Fast Real-Time PCR system (Applied Biosys-
tems). PCR conditions used were 95C for 10 min,
followed by 40 amplification cycles (95C for 15 s, 60C
for 1 min). Data were normalized against b-actin and
aldolase. Controls, methods, and primer design were
performed as described [30]. The primer sequences are
listed in Table 1.
Analysis of PAP/RegIII Protein in Ileal Mucosa
Ileum paraffin sections were immunostained with a goat
polyclonal antibody against rat PAP/RegIII (1:50) (PAP/
RegIII #AF 1996; R&D Systems, Minneapolis, MN). This
antibody cannot discriminate between PAP1 and RegIII
(PAP3), but since both PAP1 and PAP3 fall within the
PAP/RegIII group, this discrimination is not essential for
our investigation [16]. Western blot analysis of total
mucosal homogenates showed that the antibody bound to a
single size protein band only, indicating specific binding of
the antibody. Localization of Paneth cells was confirmed
by immunostaining for lysozyme with ready-to-use anti-
lysozyme (N1515; Dako). DAB peroxidase substrate kit
(Dako) was used for signal detection of the horseradish
peroxidase (HRP)-labeled secondary antibody, according
to the manufacturer’s protocol.
PAP/RegIII protein expression in the ileal mucosa was
semi-quantified by light microscopy as follows: total length
of (bottom) crypt to villus (tip) and part of this length
stained positive for PAP/RegIII were measured. The length
stained positive for PAP/RegIII was expressed as per-
centage of total crypt-villus length. For each tissue section
three completely visible crypt-villus axes were analyzed,
scored, and averaged for that particular rat. All histological
slides were recoded before microscopy to ensure blind
scoring and to prevent observer’s bias.
Analysis of PAP/RegIII Protein in Feces
Total 24-h feces were lyophilized in a manifold freeze
dryer (FD5515; Ilshin Laboratory Co., Ltd, Seoul, South
Korea) and pooled per treatment group on the basis of
individual daily fecal dry weight excretion. Proteins were
isolated from lyophilized feces pools as described else-
where [18] with a few modifications. Briefly, 100 mg of
feces was homogenized in 500 ll buffer containing
50 mmol/l Tris–HCl (pH7.5), 100 mmol/l NaCl, 1 mmol/l
EDTA, and Complete Protease Inhibitor Cocktail (Roche).
After centrifugation (2 min at 15,000g), the supernatant
Table 1 Primer sequences
Gene Acc. no. Forward primer (50?30) Reverse primer (50?30)
PAP1 NM_053289 GACTCCATGACCCCACTCTTG GCAGACGTAGGGCAACTT CAC
PAP3 NM_173097 GCTTCCTTTGTGTCCTCCTTGATT TACTCCACTCCCATCCACCTCTG
b-actin NM_031144 CTTTCTACAATGAGCTGCGTGTG GTCAGGATCTTCATGAGGTAGTCTGTC
Aldolase NM_012495 ATGCCCCACCCATACCCAGCACT AGCAGCAGTTGGCGGTAGAAGCG
Sequences of primers used for quantitative real-time PCR analysis. Acc. no. describes the accession number of the used sequence ID
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was taken, and its protein concentration was determined
using DC protein assay kit (Bio-rad Laboratories,
Veenendaal, The Netherlands) according to the manufac-
turer’s protocol. Then 45 lg of protein was denatured at
100C for 3 min in Tricine sample buffer (Bio-rad Labora-
tories), subjected to SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) (4% stacking gel, 14% separation gel), and
transferred to a PVDF membrane (Bio-rad Laboratories).
After blocking, the membranes were incubated with the
PAP/RegIII antibody (1:100). The signal of the secondary
HRP-conjugated antibody was detected using the ECL Plus
chemiluminescent detection kit (GE Healthcare, Den Bosch,
The Netherlands).
To evaluate recovery of PAP/RegIII protein in feces,
3 9 50 mg of the pre-infection feces pool, from animals
fed the control diet, was homogenized in PBS. One of these
three samples was spiked with 1 lg recombinant rat PAP
(recPAP alias PAP1; pre-release reagent from R&D Sys-
tems Inc.). The second sample was heat inactivated by
incubation at 75C for 10 min, then cooled down to room
temperature and identically spiked with the recombinant
protein. PBS was added to the third sample and used as
negative control. Subsequently, the three samples were
incubated at 37C for 1 h, and protein was isolated and
analyzed by immunoblotting as described above.
Analysis of Antimicrobial Activity
To assess antimicrobial activity of rat PAP/RegIII against
gram-negative S. enteritidis and gram-positive Listeria
monocytogenes (strain EGD-e, strain NIZO2364, NIZO
Food Research, Ede, The Netherlands), analysis was per-
formed exactly as described [8]. Briefly, target organisms
were grown in brain-heart infusion (BHI) broth and
resuspended in 25 mM 2-(N-morpholino)ethanesulfonic
acid (MES) (pH 6), containing 25 mM NaCl. The initial
bacterial concentration of the incubates was 106 CFU/ml,
and recPAP was added to a final concentration of 4 and
10 lM. After incubation for 2 and 24 h at 37C, viable
bacteria were quantified by plating ten-fold dilutions on
BHI agar plates.
To mimic the environment in which PAP/RegIII is
proposed to function as antimicrobial peptide, we per-
formed a similar antimicrobial activity assay, but replaced
the MES buffer by sterile fecal water extracts from non-
infected animals fed the control diet. Fecal water was
prepared as described [37]. Purified recPAP was added to
fecal water incubates to a final concentration of 4 and
10 lM, and viable pathogens were quantified after 2 and
24 h of incubation as described above. Experiments were
performed in duplicate.
A control experiment was performed to check correct
folding and thus binding activity of recPAP as described
elsewhere [8]. Briefly, 10 lg recPAP was added to 50 lg
insoluble Bacillus subtilis peptidoglycan (Sigma–Aldrich)
and pelleted. Pellet and supernatant fractions were ana-
lyzed on recPAP content by SDS-PAGE (as described
above).
Statistical Analysis
Data from the non-infected rats fed the control or calcium
diet were pooled as no diet-induced differences were
observed. All data are expressed as means ± SE, except
for PCR results, which are individually plotted in addition
to indication of groups’ mean. Data were tested for nor-
mality by the Kolmogorov-Smirnov test. If normally
distributed, differences between means were tested for
significance using one-way ANOVA and/or Student’s t test
(two-tailed). For non-normally distributed data, differences
between means were tested for their significance using the
non-parametric Kruskall-Wallis ANOVA and/or Mann–
Whitney U test (two-tailed). Statistical significance was set
at P \ 0.05.
Results
Animals and Food Intake
All data from one animal in the calcium group (followed
until day 7 or 8 after infection) were excluded from the
study results because that rat suffered from pneumonia due
to oropharyngeal reflux of the S. enteritidis suspension. At
the start of the experiment, mean body weight of the ani-
mals was 245 g. Average body weight gain (mean before
infection 5 g/day, after infection 3.3 g/day) and food intake
(mean 17 g dry weight/day; not affected by Salmonella
infection) were not affected by dietary treatment.
Fecal Excretion and Translocation of Salmonella
As expected, no Salmonella could be detected in feces
collected before infection of the animals. The first days
after Salmonella infection, rats fed the calcium diet had
approximately ten-fold less Salmonella in their feces than
rats fed the control diet (P \ 0.05; Table 2), reflecting
reduced intestinal colonization of this pathogen. Further-
more, translocation of Salmonella was inhibited in rats on
the calcium diet as measured by the infection-induced
increase in urinary NOx excretion. Total infection-induced
urinary NOx excretion (area under the curve) of the calcium
group was significantly lower than that of the control group
(P \ 0.05; Table 2). Results are in accordance with pre-
vious infection studies of our laboratory [3, 4, 26].
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Ileal Mucosal Inflammation
Compared to non-infected animals, ileal MPO levels
increased 12-fold in the Salmonella-infected control group
(P \ 0.05; Table 2) and 5-fold in the calcium group on
days 3–4 post-infection. Although post-infection MPO
levels in the calcium-supplemented rats were less than half
of those detected in the control group, the difference did
not reach statistical significance. This was likely due to the
relatively large inter-individual variation observed in the
Salmonella-infected control group.
Effect of Infection and Dietary Calcium Intervention
on PAP/RegIII mRNA and Protein Expression in Ileal
Mucosa
During infection, ileal PAP1 was expressed three-fold
higher than PAP3 (PAP1/actin was 0.8 and 0.7 and PAP3/
Actin was 0.29 and 0.27 in control and calcium groups,
respectively). Salmonella infection of rats fed the control
diet increased PAP1 mRNA 2.4-fold, whereas no up-
regulation was observed in calcium-supplemented infected
rats (P \ 0.05, Fig. 1a). Furthermore, compared to non-
infected rats, a 3.6- and 1.8-fold induction of PAP3 mRNA
was observed in infected rats fed the control and calcium
diet, respectively (Fig. 1b).
Little PAP/RegIII protein was detected in the ileum
mucosa of non-infected rats, whereas Salmonella infected
animals showed an increased number of cells staining
positive for PAP/RegIII protein (Fig. 2). PAP/RegIII pro-
tein was detected specifically in enterocytes at the crypt-
villus junction. The protein was not detected within goblet
cell thecae. After infection the number of PAP/RegIII-
positive enterocytes increased towards both villus tips and
crypts’ bottom. So, a larger area of the surface epithelium
stained positive for PAP/RegIII after infection. Semi-
quantification showed that the percentage of total crypt-
villus length stained positive for PAP/RegIII protein
increased 34% after Salmonella infection in the control
group (P \ 0.05; Fig. 3). In contrast, no significant
increase in PAP/RegIII protein was observed in calcium-
supplemented infected animals (Fig. 3). PAP/RegIII
Table 2 Fecal Salmonella excretion, translocation-induced urinary excretion of nitric oxide metabolites (NOx) and mucosal myeloperoxidase
Day after
infection
Non-infected Infected
Control Calcium
Fecal Salmonella (log CFU/g) Day 1 n.d. 7.2 ± 0.3a 6.3 ± 0.3b
Day 3 n.d. 6.2 ± 0.4a 4.9 ± 0.3b
Day 7 n.d. 4.7 ± 0.4a 4.2 ± 0.5a
Infection-induced urinary NOx (lmol/7 days) Days 1–7 0 73 ± 14
a 25 ± 5b
Ileal mucosal myeloperoxidase (ng/mg protein) Day 3/4 11 ± 3a 127 ± 52b 60 ± 17b
Values are means ± SE, n = 8 per infected group and n = 5 for the non-infected control group. Differences between groups were tested for
statistical significance using Student’s t test (two-sided), except for myeloperoxidase data, which were tested by non-parametric Kruskall–Wallis
ANOVA followed by Mann–Whitney U test (two-sided). Values in the same row not sharing the same letter are significantly different
(P \ 0.05); n.d. indicates not detected
Fig. 1 Relative pancreatitis-associated protein 1 (PAP1, panel A) and
pancreatitis-associated protein 3 (PAP3, panel B) mRNA expression
in ileal mucosa due to Salmonella infection in rats fed the control or
calcium-supplemented diet. Individual values were first normalized to
b-actin expression. These normalized data were used to calculate
relative expression levels by setting the mean expression level of non-
infected rats fed the identical diet at one. The mean of each diet group
(n = 9) is indicated by a line. Differences between the calcium and
control group were tested for statistical significance using Student’s t
test (two-sided). The asterisk indicates P \ 0.05. Identical results
were found when signals were normalized to aldolase (data not
shown)
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protein was not detected in the ileal Paneth cells located at
the deep crypt bottom as confirmed by Paneth cell-specific
staining of the lysozyme (data not shown).
Presence of PAP/RegIII in Feces
Immunoblotting revealed the presence of PAP/RegIII
protein in feces (Fig. 4a, lanes 1–10). Similar to the PAP/
RegIII levels in the ileum mucosa, PAP/RegIII protein in
feces of rats fed the control diet was considerably increased
from 3 to 4 days and remained steady until day 7 after
infection. This infection-induced increase in fecal PAP/
RegIII was less in calcium-supplemented infected animals.
However, basal fecal PAP/RegIII levels in non-infected
rats were slightly higher in the calcium group than in the
control group.
Purified recPAP protein showed a single band of
approximately 16 kDa, which is identical to the size of
PAP/RegIII detected in ileum mucosa (Fig. 4b, lanes 4 and
5). When recPAP was added to feces it was hydrolyzed into
two smaller forms. RecPAP incubated with pre-infection
feces formed identical-sized bands to that seen in feces of
infected rats (data not shown). Adding recPAP to heat-
inactivated feces largely prevented subsequent hydrolysis
and merely preserved the 16-kDa band (Fig. 4b, lanes 2
and 3).
Antimicrobial Activity
No antimicrobial activity could be detected when 4 or
10 lM recPAP was incubated with L. monocytogenes or S.
enteritidis in a MES buffer system (Fig. 5). Also, no bac-
tericidal or bacteriostatic activity of rat PAP was noticed
A
B
non- control calcium  
infected
infected
12.5x
40x
Fig. 2 Pancreatitis-associated
protein/regenerating gene III
(PAP/RegIII) protein expression
in the ileal mucosa of non-
infected and Salmonella-
infected rats fed either the
control or calcium-
supplemented diet. PAP/RegIII
protein was present in
enterocytes at the crypt-villus
junction (panel A, 912.5; panel
B, 940). The number of PAP/
RegIII-positive cells increased
after infection, especially in the
direction of villus tips (panel
A). Dietary calcium reduced
PAP/RegIII expression in
infected animals. No staining
was observed in sections
incubated without primary
antibody (data not shown). All
sections were counterstained
with haematoxylin to visualize
nuclei
Fig. 3 Pancreatitis associated protein/regenerating gene III (PAP/
RegIII) protein expression in the ileum mucosa of non-infected
(n = 5) and Salmonella-infected rats fed either the control (n = 9) or
calcium-supplemented (n = 9) diet. Immunohistochemical slides
(representative images are shown in Fig. 2) were used to quantify
the percentage of total crypt-villus length stained positive for PAP/
RegIII. Total crypt-villus length was not affected by infection or
calcium supplementation. Slides were recoded before microscopy to
guarantee blind scoring. Results are expressed as means ± SE.
Differences between groups were tested by non-parametric Kruskall–
Wallis ANOVA followed by Mann–Whitney U test (two-sided).
Different letters indicate significant differences (P \ 0.05)
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against these pathogens when fecal water was used
(Fig. 5). When the incubation time was prolonged from 2
to 24 h, results similar to that in Fig. 5 were obtained. To
investigate whether absence of antibacterial activity was
due to potential incorrect folding of the recombinant pro-
tein, binding activity was tested as described by Cash et al.
[8]. The recPAP used in the present study bound to bac-
terial peptidoglycan (data not shown).
Discussion
This study shows that upregulation of PAP/RegIII protein
expression by Salmonella infection parallels infection
severity as quantified by intestinal Salmonella colonization
and translocation. Interestingly, PAP/RegIII protein is also
present in feces, and these fecal levels reflect the concen-
tration of this protein in infected ileal mucosa.
In support of findings reported [7, 20, 25], our experi-
ments clearly showed that PAP/RegIII protein was present
in enterocytes at the crypt-villus junction of the ileal
mucosa. The protein was not detected in the goblet cells,
goblet cell thecae, or Paneth cells. Others have reported
expression of RegIIIc in mouse ileal Paneth cells isolated
by laser capture microdissection before mRNA analysis
[8]. In that study possible production of RegIIIc by other
mucosal cell types was not described. Moreover, the latter
study was performed in (ex-)germ-free mice, whereas our
and other [20] studies were performed in animals with a
conventional flora. First-time exposure of germ-free ani-
mals to micro-organisms initiates a period of intense
contact between microbes and the gut mucosa, until their
naı¨ve immune system has matured and, e.g., secretion of
sIgA is normalized [32]. Therefore, results obtained in
germ-free animals should be extrapolated with caution, as
those might not be relevant for the normal host with a
conventional flora. Furthermore, differences between ani-
mal species and the various RegIII isoforms should be
considered. However, the ileal PAP/RegIII localization
results of the present study are in line with those reported in
mice [25], so there is no evidence that mice behave dif-
ferently from rats in this respect. Other studies reporting
Paneth cells as expression site mostly concerned so-called
metaplastic Paneth cells in the colon of IBD patients [11,
13]. As Paneth cells are absent in the healthy colon, it can
be questioned whether these cells are identical to ileal
Paneth cells.
Increased mRNA levels of PAP or Reg in the intestinal
mucosal after bacterial infection have been reported by our
and other groups [23, 24, 30]. We now confirmed that this
increase actually occurs at the protein level. The former
Fig. 4 Effect of Salmonella infection and dietary calcium on
pancreatitis-associated protein/regenerating gene III (PAP/RegIII)
secretion in feces with time. Lyophilized feces were pooled per group
(n = 9 and n = 8 for control and calcium group, respectively) and
per 2 days. SDS-PAGE gels were loaded with equal quantities of
fecal protein and analyzed for PAP/RegIII (panel A, lanes 1–10) by
using PAP/RegIII anti-serum. Recombinant rat pancreatitis-associated
protein (recPAP) showed a single band (panel B, lane 5), similar to
PAP/RegIII detected in the ileum mucosa of animals fed the control
diet (panel B, lane 4). RecPAP incubated with pre-infection feces
from rats fed the control diet was hydrolyzed into two smaller
fragments (panel B, lane 2). When run on one gel, these fragments
were of identical size as those found in fecal extracts of infected rats
(data not shown). Heat inactivation of feces before addition of recPAP
largely prevented hydrolysis of the protein (panel B, lane 3). Non-
spiked feces (from non-infected rats) was added to lane 1 and served
as negative control. No signal was detected when immunoblots were
incubated without primary antibody (data not shown)
Fig. 5 Rat PAP lacks anti-bacterial activity against L. monocytoge-
nes (black bars) and S. enteritidis (white bars) in vitro. Bacteria were
incubated in MES buffer or fecal water extract (FW) with 0, 4 or
10 lM recombinant rat PAP (PAP). Pathogens were also grown in
brain–heart infusion (BHI) broth as positive control. The initial
bacterial concentration in the incubates was 106 colony-forming units
per ml (CFU/ml). After incubation for 2 h at 37C, viable bacteria
were quantified by plating serial dilutions. The increase (positive
values) or decrease (negative values) in viable pathogen counts in
comparison with t = 0 is expressed as D log CFU/ml. Elongation of
the incubation time to 24 h resulted in similar results (data not
shown). The assays were performed in duplicate
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and our results indicate that PAP/RegIII expression is
triggered by increased microbial-epithelial contact at
mucosal surfaces. In order to establish infection, foodborne
pathogens like S. enteritidis and ETEC bind to the small
intestinal mucosa by using adhesins or colonization factors,
which are known virulence factors [10, 27, 28]. Situations
of increased host epithelium-microbial contact often coin-
cide with gut mucosal inflammation, especially when
pathogenic bacteria are involved [1]. Inflammation in
general is also suggested as the trigger for PAP/RegIII
upregulation, as increased mRNA levels have been docu-
mented in inflamed colonic mucosa from patients with
active IBD [11, 25] as well as in experimental models of
colitis [25, 36]. It should be realized that during active
inflammation the mucosa might be damaged, its barrier
function impaired, and mucosal cells are likely more
exposed to micro-organisms from the gut lumen in com-
parison to a healthy non-inflamed mucosa [22, 33, 34].
Hence, it is very difficult to point out whether it is the
inflammation or the microbe-host contact only that induces
PAP/RegIII upregulation. In a previous study we have
shown that PAP/RegIII mRNA is not upregulated till day 3
after oral Salmonella administration [30]. This is in line
with the time-dependent fecal PAP/RegIII excretion pat-
tern of the present study (Fig. 4a). As translocation of
Salmonella already takes place on day 1–2 [3, 30], initial
bacterial contact is less likely the main driver for PAP/
RegIII upregulation. From day 3 after oral Salmonella
administration, infection-induced mucosal inflammation is
starting, and many genes of immune function are upregu-
lated [30]. Together, these results suggest inflammation as
the trigger for PAP/RegIII increase. It is becoming
increasingly recognized that epithelial cells, besides being
crucial for absorption of nutrients and maintenance of the
gut barrier, function through an interactive process with
components of the underlying immune system. Intestinal
epithelial cells play an important role in both innate and
adaptive immune responses. Intraepithelial lymphocytes,
triggered by bacterial translocation, exist in direct contact
with epithelial cells, and their interaction can lead to epi-
thelial expression of a variety of regulatory molecules, e.g.,
involved in adhesion, bacterial recognition and antigen
presentation, chemotaxis, and mucosal inflammation [27].
Follow-up infection studies, for instance in immuno-defi-
cient animal models, can reveal whether this interplay is
important for PAP expression and functionality. Further-
more, a study in which SPF animals are inoculated with an
organism known to adhere to the gut mucosa without
causing inflammation can show whether inflammation is
indeed required for PAP/RegIII upregulation.
The function of intestinal PAP/RegIII is of most interest.
Studies suggesting antimicrobial activity of PAP/RegIII
have shown that mouse RegIIIc was able to bind to gram-
positive bacteria in vitro [8]. Analogous to defensins, PAP/
RegIII is a small protein (±16 kDa); it consists of a
secretion signal and a carbohydrate-binding motif. Carbo-
hydrates are present in the gut mucosa (for example,
mucins) and on the surface of gram-positive bacteria. Up to
now, actual secretion of PAP/RegIII to the gut lumen has
only been briefly mentioned without showing data [20].
The results of our infection study clearly show that PAP/
RegIII is present in feces and is upregulated within the
same timeframe as the mucosal levels of this protein. This
suggests that fecal PAP/RegIII originates from ileal
mucosa, and the gut lumen might be the functional site.
Our recovery experiments identified hydrolysis of PAP/
RegIII in intestinal contents (Fig. 4b). RecPAP incubated
with pre-infection feces formed identical-sized bands to
that seen in the feces of infected mice. The hydrolysis of
PAP might activate its function, as shown for pancreatic-
derived PAP/RegIII [15]. Therefore, the proposed antimi-
crobial properties of PAP/RegIII reported by others [8]
were further explored. Besides repetition of the bactericidal
activity assay in MES buffer as performed [8], we also
included incubates of L. monocytogenes and S. enteritidis
in fecal water in the presence or absence of PAP/RegIII.
Fecal water, containing intestinal enzymatic activity and
gut surfactants like bile acids and fatty acids, better rep-
resents the natural (in vivo) environment than a clean MES
buffer system. The concentration of recPAP used in our
experiments was 4 lM, as this was the estimated concen-
tration in feces after Salmonella infection as detected by
immunoblotting. Moreover, this concentration fits well in
the range applied and found active in reported experiments
[8]. In addition, a higher PAP concentration (10 lM) and a
longer incubation time were included. Remarkably, we
found no evidence for any bactericidal or bacteriostatic
activity against L. monocytogenes or S. enteritidis. These
results are in line with unpublished results from another
research group, who also failed to confirm the antimicro-
bial activities of rat PAP as well as human PAP (J. L.
Iovanna, personal communications). In view of the sug-
gested exclusive antimicrobial function against gram-
positive bacteria [8], it also remains unexplained why
gram-negative bacterial pathogens, like S. enteritidis in our
present and previous [30] studies and ETEC [23], are the
most potent inducers of intestinal PAP/RegIII, whereas this
mucosal protein has no anti-bacterial effect against its
inducers. It might indicate that PAP/RegIII functions only
at the mucosal interface, where most of the protein would
be unhydrolyzed still containing its signal sequence. On the
other hand, it cannot be excluded that hydrolysis of PAP/
RegIII in the intestinal lumen reflects activation, as is
suggested for pancreatic derived PAP/RegIII [15], rather
than inactivation of a function yet to be discovered. Fur-
thermore, PAP/RegIII will face a myriad of carbohydrates
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associated with the mucosa upon epithelial secretion. In
that respect, binding of PAP/RegIII to mucins and effects
on gut barrier function are areas to be investigated in the
near future. It should be noticed that PAP1, or RegIIIß,
applied in our in vitro experiments is a homologue, but not
the orthologue of mouse RegIIIc, which was used in pub-
lished in-vitro experiments on bactericidal activity. It
might well be that PAP1 (RegIIIb) and RegIIIc have dif-
ferent functions. Binding assays showed that the
recombinant-rat-PAP protein we used was able to bind
peptidoglycan, indicating proper folding of the protein.
Diet is known to modulate gene and protein expression
in the gut. As we used a calcium intervention to modulate
severity of Salmonella infection in rats, we cannot exclude
a direct effect of dietary calcium on intestinal PAP
expression. In fact, the Western blots seemed to indicate
that PAP protein in feces of non-infected rats fed the cal-
cium diet was higher than that of non-infected rats fed the
control diet (Fig. 4a, lanes 1 and 6). Despite a possible
difference in basal excretion, the situation was totally
reversed after infection, showing the highest ileal and fecal
PAP/RegIII protein levels in the low-calcium control
group.
In conclusion, this study demonstrates that PAP/RegIII
protein levels present in the ileal mucosa and feces reflect
infection severity. As fecal PAP/RegIII levels can be
monitored non-invasively and with time, its use as a new
infection and/or inflammation marker in animal and in
human studies is worthwhile to further explore. Consider-
ing the growing interest in intestinal PAP/RegIII,
elucidation of its functionality is scientifically important
and might be achieved by the generation of PAP/RegIII
knock-out animals. Recently, a PAP/HIP knock-out mice
study on experimentally induced pancreatitis was pub-
lished [14]. Investigation of the reaction of these mice to
intestinal infection and inflammation would be very
interesting.
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